Exercise:AntibodyStructurePrediction ans: Difference between revisions

From 22145
Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
__TOC__
__TOC__


= Antibody Structure Modelling Answers =
= Antibody Structure Modelling — Answers =
 
'''Case study:''' SI135 antibody from chronic lymphocytic leukemia (CLL)
 
'''LYRA prediction:''' [https://services.healthtech.dtu.dk/cgi-bin/webface2.cgi?jobid=6AD8166000282F67166ED625&wait=20 View the original modelling job]


''SI135 CLL antibody modelling exercise.''


== Part 1 — Antibody modelling with LYRA ==
== Part 1 — Antibody modelling with LYRA ==


=== Q1. Framework template sequence similarity ===
=== Q1. Framework template selection ===


'''Q1: what is the sequence similarity of the best H and L templates for the framework (FW)?'''
'''Answer:'''


'''Answer:'''
LYRA selected the following framework templates:


{| class="wikitable"
{| class="wikitable"
! Region
! Chain
! Selected template
! Selected template
! Sequence identity
! Sequence identity
! BLOSUM score
|-
|-
| Heavy-chain framework (VH)
| Heavy (VH)
| [TO VERIFY]
| '''3H42'''
| [TO VERIFY]
| '''80.5%'''
| 514
|-
|-
| Light-chain framework (VL)
| Lambda light (VL)
| [TO VERIFY]
| '''1W72'''
| [TO VERIFY]
| '''85.7%'''
| 518
|}
|}


The framework templates are chosen according to their sequence compatibility with the target antibody, taking into account the CDR canonical structures.
Interestingly, 2UZI has a slightly higher sequence identity to the heavy chain (81.7%), but LYRA selects 3H42, which has a higher BLOSUM score and compatible canonical structures.


The framework is relatively conserved among antibodies, and a high sequence identity usually facilitates reliable homology modelling.
This illustrates that template selection depends on more than sequence identity alone.
 
LYRA reports both sequence identity and BLOSUM62 similarity scores. These should not be confused: sequence identity measures identical residues, whereas BLOSUM62 also accounts for conservative substitutions.


=== Q2. Light-chain type ===
=== Q2. Light-chain type ===
'''Q2: What is the light chain type? Is it the most common in humans?'''


'''Answer:'''
'''Answer:'''


The SI135 antibody contains a '''lambda (λ) light chain'''.
The SI135 antibody has a '''lambda (λ) light chain'''.
 
The sequence is consistent with the IGLV3-21 light-chain family, which is associated with a well-characterized subset of CLL antibodies.
 
Lambda is not the most common light-chain type in humans. Approximately 60% of human antibodies contain kappa (κ) light chains and 40% contain lambda (λ) light chains, although proportions vary between individuals and tissues.


=== Q3. Sequence differences between target and template ===
Lambda is less common than kappa (κ) in human antibodies. Approximately 60% of human antibodies have kappa light chains and 40% have lambda light chains.


'''Q3: where are the differences between target and template located? Which are the most drastic that could affect the modeling process (e.g. G->W)?'''
=== Q3. Sequence differences between target and templates ===


'''Answer:'''
'''Answer:'''


The framework regions are generally more conserved than the CDRs, which are responsible for much of the sequence diversity in antibodies.
The target antibody is relatively similar to the selected framework templates, but several substitutions are observed in both framework and CDR regions.


The differences observed in the SI135 alignment should be classified according to their physicochemical properties.
Some examples from the LYRA alignments include:


Examples of substitutions with potentially important structural effects include:
{| class="wikitable"
! Region
! Template → Target
! Interpretation
|-
| Heavy-chain framework
| K → R
| Conservative substitution between positively charged residues
|-
| CDR-H1
| S → T
| Conservative polar substitution
|-
| CDR-H2
| S → N
| Changes side-chain size and hydrogen-bonding possibilities
|-
| CDR-H3
| R → N
| Removes a positive charge
|-
| CDR-H3
| Q → T
| Changes side-chain size and hydrogen-bonding properties
|-
| CDR-L2
| D → Y
| Removes a negative charge and introduces a bulky aromatic residue
|-
| CDR-L3
| L → S
| Changes from hydrophobic to polar
|-
| CDR-L3
| S → D
| Introduces a negative charge
|-
| CDR-L3
| A → H
| Introduces a larger, potentially ionizable side chain
|-
| CDR-L3
| D → P
| Removes a negative charge and introduces a residue that restricts backbone conformation
|}


* G → W: introduces a large aromatic side chain in place of a very small and flexible residue.
The CDR-L2 substitution D → Y and the CDR-L3 substitution D → P are particularly interesting because they involve substantial changes in physicochemical properties.
* A → D: introduces a negatively charged side chain.
* D → K: reverses the formal side-chain charge.
* Substitutions involving proline: may restrict local backbone conformations.


Conservative substitutions, such as I → V or D → E, are generally less disruptive.
In the light-chain framework alignment, a D → K substitution near the C-terminus also reverses the side-chain charge.


However, the structural consequences depend on the position of the substitution. A change in the buried framework can be more important than a non-conservative substitution in an exposed loop.
'''Teaching point:''' The impact of a substitution depends not only on its BLOSUM score but also on its structural location and whether the residue is buried or exposed.


'''SI135-specific substitutions:''' [TO VERIFY from the LYRA alignment]
=== Q4. CDR loop lengths and expected accuracy ===


=== Q4. CDR loop lengths ===
'''Answer:'''


'''Q4: Do the loops/CDR have the same length in target and template? What does it mean, in terms of expected accuracy?'''
All six selected CDR templates have the same loop length as the corresponding SI135 target loops.


'''Answer:'''
{| class="wikitable"
! Loop
! Template
! Template sequence
! Target sequence
! Length
|-
| H1
| 3H42
| GFTFSSY
| GFTFSTY
| 7
|-
| H2
| 3H42
| SSSS
| SSSN
| 4
|-
| H3
| 2NR6
| VRQMD
| VNTMD
| 5
|-
| L1
| 2G75
| GNNIGSKS
| GNNIGSKS
| 8
|-
| L2
| 1W72
| DDS
| YDN
| 3
|-
| L3
| 3GHB
| WDSGLSADW
| WDSGSDHPW
| 9
|}


The CDR loop lengths must be compared with those of the selected structural templates.
''These are the loop-core lengths reported by LYRA. Other CDR definitions may include additional residues.''


The SI135 antibody contains the following CDR3 sequences:
Matching loop lengths generally make template-based modelling easier because no insertions or deletions are required in the loop core.


<pre>
However, there is one interesting exception in the canonical structure classification.
Heavy-chain CDR3:
ARDVNTMDV
Length: 9 amino acids


Light-chain CDR3:
For CDR-L1:
QVWDSGSDHPWV
Length: 12 amino acids
</pre>


If the target and template loops have the same length and similar conformations, the model can generally be built more reliably.
* '''Template canonical structure: 7'''
* '''Predicted canonical structure: 8'''


Differences in loop length make modelling more difficult because insertions, deletions, or alternative loop conformations must be accommodated.
Thus, although L1 has the same sequence length and an identical loop-core sequence in the selected template, the predicted canonical structure class is different.


LYRA attempts to address this by selecting separate loop templates according to loop length and predicted canonical structure.
This introduces additional uncertainty in the loop conformation.


'''SI135 target/template length differences:''' [TO VERIFY]
'''Teaching point:''' Matching loop length does not guarantee that the target and template have the same three-dimensional conformation.


=== Q5. Number and similarity of structural templates ===
=== Q5. Number of templates and most dissimilar region ===


'''Q5: How many templates were used? Which is the region for which the template is more dissimilar to the target sequence?'''
'''Answer:'''


'''Answer:'''
LYRA uses '''five distinct PDB templates''' to construct the SI135 antibody model:


LYRA uses structural templates for the heavy- and light-chain frameworks and can select additional templates for individual CDR loops.
{| class="wikitable"
! PDB template
! Regions modelled
|-
| '''3H42'''
| Heavy-chain framework, H1, H2 and heavy/light chain packing
|-
| '''2NR6'''
| H3
|-
| '''1W72'''
| Light-chain framework and L2
|-
| '''2G75'''
| L1
|-
| '''3GHB'''
| L3
|}


There are eight modelled regions in total:
A total of eight framework/loop regions are modelled, but several use the same structural template.


* Two framework regions (VH and VL).
The sequence identity within each selected loop core is:
* Three CDRs in the heavy chain.
* Three CDRs in the light chain.


However, the number of '''distinct PDB templates''' may be smaller than eight because several regions can be modelled using the same structure.
{| class="wikitable"
! Loop
! Identical residues
! Identity
|-
| H1
| 6/7
| 85.7%
|-
| H2
| 3/4
| 75.0%
|-
| H3
| 3/5
| 60.0%
|-
| L1
| 8/8
| 100%
|-
| L2
| 1/3
| '''33.3%'''
|-
| L3
| 5/9
| 55.6%
|}


'''Number of distinct templates for SI135:''' [TO VERIFY]
'''CDR-L2 has the lowest direct sequence identity''' between its selected loop template and the target.


'''Region with the least similar template:''' [TO VERIFY]
CDR-L3 also contains several substitutions, including the potentially important D → P change.


CDR-H3 is frequently a challenging region to model because of its structural diversity, although the relatively long CDR-L3 of SI135 is also of particular interest.
The loop identities above are calculated directly from the sequences reported in the PDB annotations, not from the overall framework-template scores.


== Part 2 — Exploring the antibody structure ==
== Part 2 — Exploring the antibody structure in PyMOL ==


=== Q6. Shape of the antigen-binding site ===
=== Q6. Shape of the antigen-binding site ===


'''Q6: What is the general shape of the ABS: flat, a pocket, a mountain or a groove?'''
'''Expected answer:'''


'''Answer:'''
The antigen-binding site is formed by the six CDR loops.


The antigen-binding site is formed by the six CDR loops of the variable heavy and light chains.
Its overall shape should be classified by displaying the predicted antibody as a molecular surface and examining the arrangement of these loops.


Its surface can be classified qualitatively as flat, pocket-like, groove-like, or protruding (mountain-like).
'''SI135 classification:''' To be confirmed from the PyMOL surface representation.


'''SI135 classification:''' [TO VERIFY from the LYRA structure displayed as a surface]
The LYRA sequence alignments do not establish whether the binding site is flat, pocket-like, groove-like or mountain-like.


The classification should be based on the overall geometry of the combined CDR surface rather than the shape of a single loop.
The classification is qualitative, and students should justify their answer based on the model.


''Teaching point:'' The shape of the antigen-binding site can provide clues about molecular recognition, but it does not directly identify the antigen.
=== Q7. Longest and most protruding CDR ===
 
=== Q7. Longest and most protruding CDR loop ===
 
'''Q7: Which loop is the longest and protruding the most? Is this the most common case?'''


'''Answer:'''
'''Answer:'''


SI135 has a relatively short heavy-chain CDR3 and a long light-chain CDR3.
According to LYRA, the six loop-core lengths are:


<pre>
{| class="wikitable"
CDR-H3: ARDVNTMDV      (9 residues)
! Loop
CDR-L3: QVWDSGSDHPWV  (12 residues)
! Length
</pre>
|-
| H1
| 7
|-
| H2
| 4
|-
| H3
| 5
|-
| L1
| 8
|-
| L2
| 3
|-
| '''L3'''
| '''9'''
|}


Using the short, structurally defined CDR boundaries, '''CDR-L3 is the longest CDR in this antibody'''.
The '''longest loop is CDR-L3'''.


The loop that protrudes the most should be identified by inspecting the three-dimensional structure.
This is notable because CDR-H3 is often the longest and most structurally variable CDR in human antibodies.


'''Most protruding loop:''' [TO VERIFY in PyMOL]
The loop that protrudes furthest should be determined from the three-dimensional structure, since length alone does not determine protrusion.


This is an unusual feature compared with the common situation in which CDR-H3 is the most variable and often the most prominent loop.
'''Most protruding loop:''' To be confirmed by visual inspection in PyMOL.
 
A long CDR does not necessarily protrude further than a short CDR, because its conformation can fold back towards the antibody framework.


== Part 3 — Somatic mutations ==
== Part 3 — Somatic mutations ==


=== Q8. Mutations potentially affecting antigen binding ===
=== Q8. Somatic mutations near the CDRs ===
 
'''Q8: Which Mutations are located inside/near the CDRs? Which are the ones that are most likely to have an impact on the binding of the antibody?'''
 
'''Answer:'''


The somatic mutations must be identified by comparison with the closest germline V and J sequences, using IMGT/DomainGapAlign.
'''Expected answer:'''


The SI135 sequences are consistent with IGHV3-21 and IGLV3-21 family usage, which is frequently associated with stereotyped B-cell receptors in CLL.
Somatic mutations must be identified by comparing the SI135 sequence with the closest germline immunoglobulin genes using IMGT/DomainGapAlign.


'''Exact somatic mutations:''' [TO VERIFY using IMGT]
The target-template substitutions identified by LYRA are not necessarily somatic mutations, because the structural templates are unrelated antibody sequences rather than the germline ancestors of SI135.


Mutations within the CDRs or in framework positions supporting the CDRs are particularly interesting.
Mutations located inside the CDRs or affecting the residues that support them are particularly interesting.


Mutations are more likely to affect binding when they:
The most likely candidates to affect binding are substitutions that:


* Change the electrostatic properties of the binding site.
* Change the charge of an exposed residue.
* Introduce or remove aromatic residues.
* Introduce or remove aromatic residues.
* Change hydrogen-bonding possibilities.
* Affect hydrogen bonding.
* Alter loop conformation or flexibility.
* Change loop geometry or flexibility.
* Affect residues exposed towards the antigen.
 
Mutations affecting the charge or geometry of residues near the centre of the antigen-binding site are plausible candidates for having a functional effect.


However, the impact of a mutation cannot be established confidently from the structure alone.
'''SI135-specific mutation list:''' Requires the IMGT germline alignment.
 
''Teaching point:'' Mutations in the framework may indirectly alter binding by affecting the orientation or stability of the CDR loops.
 
Differences introduced during V(D)J recombination, especially in CDR3, should not automatically be interpreted as somatic mutations.


== Part 4 — Electrostatic properties ==
== Part 4 — Electrostatic properties ==


=== Q9. Charged residues in the CDRs ===
=== Q9. Charged CDR residues ===


'''Q9: Identify the residues in the CDRs that mostly contribute to the charge distribution.'''
'''Answer:'''


'''Answer:'''
The LYRA loop definitions allow us to identify the following charged or potentially charged residues.


The most relevant charged amino acids are:
{| class="wikitable"
! Loop
! Sequence
! Relevant residues
|-
| H1
| GFTFSTY
| None of K, R, D or E
|-
| H2
| SSSN
| None of K, R, D or E
|-
| H3
| VNTMD
| D (negative)
|-
| L1
| GNNIGSKS
| K (positive)
|-
| L2
| YDN
| D (negative)
|-
| L3
| WDSGSDHPW
| Two D residues (negative); H may be protonated
|}


* Positively charged: arginine (R), lysine (K).
The principal charged residues within these CDR definitions are therefore:
* Negatively charged: aspartate (D), glutamate (E).


For SI135, the CDR3 sequences contain several charged residues.
* One aspartate in H3.
* One lysine in L1.
* One aspartate in L2.
* Two aspartates in L3.


'''Heavy-chain CDR3:'''
The light-chain loops contain several negatively charged residues, which may contribute to negatively charged patches on the antigen-binding surface.


<pre>
However, the actual electrostatic distribution depends on the spatial arrangement of these residues.
A R D V N T M D V
  + -        -
</pre>


This loop contains:
'''Residue numbering in the provided LYRA PDB:'''


* One arginine (R), positively charged.
{| class="wikitable"
* Two aspartates (D), negatively charged.
! Loop
! Residue
! PDB position
|-
| H3
| Aspartate
| H101
|-
| L1
| Lysine
| L31
|-
| L2
| Aspartate
| L51
|-
| L3
| Aspartate
| L92
|-
| L3
| Aspartate
| L95A
|-
| L3
| Histidine
| L95B
|}


'''Light-chain CDR3:'''
Students can highlight the main charged CDR residues using the following PyMOL commands:


<pre>
<pre>
Q V W D S G S D H P W V
select charged_cdrs, (chain H and resi 101) or (chain L and resi 31+51+92+95A)
      -      -
show sticks, charged_cdrs
color yellow, charged_cdrs
</pre>
</pre>


This loop contains:
''These residue numbers refer specifically to the supplied LYRA PDB file.''
 
* Two aspartates (D), negatively charged.
* One histidine (H), which may carry a positive charge depending on its environment and pH.
 
Both CDR3 loops therefore contain negatively charged residues.
 
Other charged residues in CDR1 and CDR2 also contribute to the overall charge distribution.
 
The surface distribution must be inspected in PyMOL because residues that are close in sequence are not necessarily close in three-dimensional space.


A local concentration of aspartate residues could produce a negatively charged region at the antigen-binding surface.
=== Q10. Introducing a positive charge (optional) ===


''Teaching point:'' Electrostatic potential reflects the spatial distribution of charges, not simply the total number of charged amino acids.
'''Expected answer:'''


=== Q10. Effect of introducing a positive charge (optional) ===
Replacing an exposed negatively charged residue with lysine or arginine should make its local electrostatic environment more positive.


'''Q10: (optional) Mutate some residues in order to have a positive charge in the middle of the antigen binding site, then recalculate the electrostatic potentials. Can you see the changes?'''
For example, a D → K mutation at a solvent-exposed CDR position would reverse the formal side-chain charge.


'''Answer:'''
After recalculating the electrostatic potential, the surface coloring near the mutation should change.


Introducing a positively charged residue, such as lysine (K) or arginine (R), should increase the local positive electrostatic potential.
'''Actual changes:''' Require performing the mutation and recalculating the potential in PyMOL.


For example, replacing an exposed aspartate (D) with lysine (K) in a CDR could reverse the local charge.
A change in electrostatic potential does not necessarily improve antigen binding.


After recalculating the electrostatic potential, a change in surface coloring should become visible near the mutated residue.
== Part 5 — Comparing antibody modelling approaches ==


The extent of the change depends on the location and conformation of the new side chain.
=== Q11. LYRA versus ABodyBuilder2 ===


A more positive surface does not necessarily imply stronger antigen binding, because the properties of the antigen must also be considered.
'''Expected answer:'''


== Part 5 — Comparison of modelling approaches ==
LYRA and ABodyBuilder2 use different approaches to structure prediction.
 
=== Q11. Comparison between LYRA and ABodyBuilder2 ===
 
'''Q11: Go to the AbodyBuilder 2 site and make a new structure prediction. Download the PDB file and compare with the model generated by LYRA. Can you see some differences?'''
 
'''Answer:'''
 
LYRA and ABodyBuilder2 use different approaches to antibody structure prediction.


{| class="wikitable"
{| class="wikitable"
Line 274: Line 427:
! ABodyBuilder2
! ABodyBuilder2
|-
|-
| Traditional template-based homology modelling
| Template-based homology modelling
| Deep-learning-based structure prediction
| Deep-learning-based prediction
|-
|-
| Selects framework and CDR templates from known experimental structures
| Uses experimentally determined structural templates
| Uses a neural network trained on antibody structures
| Uses a trained neural network
|-
|-
| Uses canonical loop structures and loop grafting
| Models framework and loops using selected templates
| Learns structural patterns from training data
| Predicts the antibody structure from sequence
|-
|-
| Quality depends strongly on suitable templates
| Depends on availability and suitability of structural templates
| Provides prediction-error estimates for different antibody regions
| Provides prediction-error estimates
|}
|}


The overall immunoglobulin fold is expected to be similar in both models.
Both methods should produce a similar overall immunoglobulin fold.
 
Differences are expected to be more pronounced in variable loops, particularly where the sequence similarity to the LYRA template is low or the canonical structures differ.


Differences may occur in:
For SI135, potentially interesting regions include:


* CDR loop conformations, particularly CDR-H3 or unusual loops.
* CDR-L1, because of the canonical structure mismatch.
* Relative orientations of the heavy and light chains.
* CDR-L2, because of its low sequence identity with the selected loop template.
* Side-chain conformations.
* CDR-L3, because it contains several non-conservative substitutions.
* CDR-H3, because antibody H3 loops can have diverse conformations.


'''Specific differences between the SI135 models:''' [TO VERIFY after structural superposition]
'''Actual differences between the two SI135 predictions:''' Require the ABodyBuilder2 model for structural superposition.


The models can be compared in PyMOL using:
In PyMOL, the models can be superimposed using:


<pre>
<pre>
Line 303: Line 459:
</pre>
</pre>


Replace the object names with those used in the PyMOL session.
The object names should be adapted to the names used in the PyMOL session.
 
The RMSD obtained after structural alignment provides a quantitative measure of structural differences.
 
''Teaching point:'' Agreement between two predictions can increase confidence in a structural hypothesis, but does not establish experimental accuracy.
 
== Summary ==


This exercise illustrates several important principles:
== Take-home messages ==


* Antibody frameworks are relatively conserved, whereas CDR loops provide sequence and structural diversity.
* The SI135 antibody has a lambda light chain.
* Template-based modelling is influenced by sequence similarity, loop length, and canonical structure.
* The selected framework templates show relatively high sequence identity: 80.5% for VH and 85.7% for VL.
* CDR-H3 is often particularly variable, but other CDRs may also present modelling challenges.
* Five distinct structural templates were used to build the antibody model.
* Somatic mutations may affect antigen recognition by changing the structural or chemical properties of the binding surface.
* All six loop templates have the same lengths as their corresponding target loops.
* Electrostatic properties depend on the three-dimensional arrangement of charged residues.
* CDR-L1 has a mismatch in canonical structure classification despite matching loop length.
* Deep-learning tools provide an alternative to traditional homology modelling, but predicted structures must still be evaluated critically.
* CDR-L2 has the lowest sequence identity to its selected loop template.
* CDR-L3 is the longest loop in the LYRA model.
* Several negatively charged residues are present in the CDRs, especially in the light chain.
* Template similarity does not guarantee structural accuracy, particularly in flexible loops.


== References ==
== References ==


* [https://services.healthtech.dtu.dk/cgi-bin/webface2.cgi?jobid=6AD8166000282F67166ED625&wait=20 SI135 LYRA modelling results]
* [https://services.healthtech.dtu.dk/services/LYRA-1.0/ LYRA]
* [https://services.healthtech.dtu.dk/services/LYRA-1.0/ LYRA — DTU Health Tech]
* [https://www.imgt.org/ IMGT]
* [https://www.imgt.org/ IMGT immunogenetics]
* [https://opig.stats.ox.ac.uk/webapps/sabdab-sabpred/sabpred/abodybuilder2/ ABodyBuilder2]
* [https://opig.stats.ox.ac.uk/webapps/sabdab-sabpred/sabpred/abodybuilder2/ ABodyBuilder2]
* [https://pmc.ncbi.nlm.nih.gov/articles/PMC7015129/ Antibody sequences and antigen recognition in CLL]

Revision as of 03:27, 21 October 2026

Antibody Structure Modelling — Answers

SI135 CLL antibody modelling exercise.

Part 1 — Antibody modelling with LYRA

Q1. Framework template selection

Answer:

LYRA selected the following framework templates:

Chain Selected template Sequence identity BLOSUM score
Heavy (VH) 3H42 80.5% 514
Lambda light (VL) 1W72 85.7% 518

Interestingly, 2UZI has a slightly higher sequence identity to the heavy chain (81.7%), but LYRA selects 3H42, which has a higher BLOSUM score and compatible canonical structures.

This illustrates that template selection depends on more than sequence identity alone.

Q2. Light-chain type

Answer:

The SI135 antibody has a lambda (λ) light chain.

Lambda is less common than kappa (κ) in human antibodies. Approximately 60% of human antibodies have kappa light chains and 40% have lambda light chains.

Q3. Sequence differences between target and templates

Answer:

The target antibody is relatively similar to the selected framework templates, but several substitutions are observed in both framework and CDR regions.

Some examples from the LYRA alignments include:

Region Template → Target Interpretation
Heavy-chain framework K → R Conservative substitution between positively charged residues
CDR-H1 S → T Conservative polar substitution
CDR-H2 S → N Changes side-chain size and hydrogen-bonding possibilities
CDR-H3 R → N Removes a positive charge
CDR-H3 Q → T Changes side-chain size and hydrogen-bonding properties
CDR-L2 D → Y Removes a negative charge and introduces a bulky aromatic residue
CDR-L3 L → S Changes from hydrophobic to polar
CDR-L3 S → D Introduces a negative charge
CDR-L3 A → H Introduces a larger, potentially ionizable side chain
CDR-L3 D → P Removes a negative charge and introduces a residue that restricts backbone conformation

The CDR-L2 substitution D → Y and the CDR-L3 substitution D → P are particularly interesting because they involve substantial changes in physicochemical properties.

In the light-chain framework alignment, a D → K substitution near the C-terminus also reverses the side-chain charge.

Teaching point: The impact of a substitution depends not only on its BLOSUM score but also on its structural location and whether the residue is buried or exposed.

Q4. CDR loop lengths and expected accuracy

Answer:

All six selected CDR templates have the same loop length as the corresponding SI135 target loops.

Loop Template Template sequence Target sequence Length
H1 3H42 GFTFSSY GFTFSTY 7
H2 3H42 SSSS SSSN 4
H3 2NR6 VRQMD VNTMD 5
L1 2G75 GNNIGSKS GNNIGSKS 8
L2 1W72 DDS YDN 3
L3 3GHB WDSGLSADW WDSGSDHPW 9

These are the loop-core lengths reported by LYRA. Other CDR definitions may include additional residues.

Matching loop lengths generally make template-based modelling easier because no insertions or deletions are required in the loop core.

However, there is one interesting exception in the canonical structure classification.

For CDR-L1:

  • Template canonical structure: 7
  • Predicted canonical structure: 8

Thus, although L1 has the same sequence length and an identical loop-core sequence in the selected template, the predicted canonical structure class is different.

This introduces additional uncertainty in the loop conformation.

Teaching point: Matching loop length does not guarantee that the target and template have the same three-dimensional conformation.

Q5. Number of templates and most dissimilar region

Answer:

LYRA uses five distinct PDB templates to construct the SI135 antibody model:

PDB template Regions modelled
3H42 Heavy-chain framework, H1, H2 and heavy/light chain packing
2NR6 H3
1W72 Light-chain framework and L2
2G75 L1
3GHB L3

A total of eight framework/loop regions are modelled, but several use the same structural template.

The sequence identity within each selected loop core is:

Loop Identical residues Identity
H1 6/7 85.7%
H2 3/4 75.0%
H3 3/5 60.0%
L1 8/8 100%
L2 1/3 33.3%
L3 5/9 55.6%

CDR-L2 has the lowest direct sequence identity between its selected loop template and the target.

CDR-L3 also contains several substitutions, including the potentially important D → P change.

The loop identities above are calculated directly from the sequences reported in the PDB annotations, not from the overall framework-template scores.

Part 2 — Exploring the antibody structure in PyMOL

Q6. Shape of the antigen-binding site

Expected answer:

The antigen-binding site is formed by the six CDR loops.

Its overall shape should be classified by displaying the predicted antibody as a molecular surface and examining the arrangement of these loops.

SI135 classification: To be confirmed from the PyMOL surface representation.

The LYRA sequence alignments do not establish whether the binding site is flat, pocket-like, groove-like or mountain-like.

The classification is qualitative, and students should justify their answer based on the model.

Q7. Longest and most protruding CDR

Answer:

According to LYRA, the six loop-core lengths are:

Loop Length
H1 7
H2 4
H3 5
L1 8
L2 3
L3 9

The longest loop is CDR-L3.

This is notable because CDR-H3 is often the longest and most structurally variable CDR in human antibodies.

The loop that protrudes furthest should be determined from the three-dimensional structure, since length alone does not determine protrusion.

Most protruding loop: To be confirmed by visual inspection in PyMOL.

Part 3 — Somatic mutations

Q8. Somatic mutations near the CDRs

Expected answer:

Somatic mutations must be identified by comparing the SI135 sequence with the closest germline immunoglobulin genes using IMGT/DomainGapAlign.

The target-template substitutions identified by LYRA are not necessarily somatic mutations, because the structural templates are unrelated antibody sequences rather than the germline ancestors of SI135.

Mutations located inside the CDRs or affecting the residues that support them are particularly interesting.

The most likely candidates to affect binding are substitutions that:

  • Change the charge of an exposed residue.
  • Introduce or remove aromatic residues.
  • Affect hydrogen bonding.
  • Change loop geometry or flexibility.

SI135-specific mutation list: Requires the IMGT germline alignment.

Part 4 — Electrostatic properties

Q9. Charged CDR residues

Answer:

The LYRA loop definitions allow us to identify the following charged or potentially charged residues.

Loop Sequence Relevant residues
H1 GFTFSTY None of K, R, D or E
H2 SSSN None of K, R, D or E
H3 VNTMD D (negative)
L1 GNNIGSKS K (positive)
L2 YDN D (negative)
L3 WDSGSDHPW Two D residues (negative); H may be protonated

The principal charged residues within these CDR definitions are therefore:

  • One aspartate in H3.
  • One lysine in L1.
  • One aspartate in L2.
  • Two aspartates in L3.

The light-chain loops contain several negatively charged residues, which may contribute to negatively charged patches on the antigen-binding surface.

However, the actual electrostatic distribution depends on the spatial arrangement of these residues.

Residue numbering in the provided LYRA PDB:

Loop Residue PDB position
H3 Aspartate H101
L1 Lysine L31
L2 Aspartate L51
L3 Aspartate L92
L3 Aspartate L95A
L3 Histidine L95B

Students can highlight the main charged CDR residues using the following PyMOL commands:

select charged_cdrs, (chain H and resi 101) or (chain L and resi 31+51+92+95A)
show sticks, charged_cdrs
color yellow, charged_cdrs

These residue numbers refer specifically to the supplied LYRA PDB file.

Q10. Introducing a positive charge (optional)

Expected answer:

Replacing an exposed negatively charged residue with lysine or arginine should make its local electrostatic environment more positive.

For example, a D → K mutation at a solvent-exposed CDR position would reverse the formal side-chain charge.

After recalculating the electrostatic potential, the surface coloring near the mutation should change.

Actual changes: Require performing the mutation and recalculating the potential in PyMOL.

A change in electrostatic potential does not necessarily improve antigen binding.

Part 5 — Comparing antibody modelling approaches

Q11. LYRA versus ABodyBuilder2

Expected answer:

LYRA and ABodyBuilder2 use different approaches to structure prediction.

LYRA ABodyBuilder2
Template-based homology modelling Deep-learning-based prediction
Uses experimentally determined structural templates Uses a trained neural network
Models framework and loops using selected templates Predicts the antibody structure from sequence
Depends on availability and suitability of structural templates Provides prediction-error estimates

Both methods should produce a similar overall immunoglobulin fold.

Differences are expected to be more pronounced in variable loops, particularly where the sequence similarity to the LYRA template is low or the canonical structures differ.

For SI135, potentially interesting regions include:

  • CDR-L1, because of the canonical structure mismatch.
  • CDR-L2, because of its low sequence identity with the selected loop template.
  • CDR-L3, because it contains several non-conservative substitutions.
  • CDR-H3, because antibody H3 loops can have diverse conformations.

Actual differences between the two SI135 predictions: Require the ABodyBuilder2 model for structural superposition.

In PyMOL, the models can be superimposed using:

align ABodyBuilder2, LYRA

The object names should be adapted to the names used in the PyMOL session.

Take-home messages

  • The SI135 antibody has a lambda light chain.
  • The selected framework templates show relatively high sequence identity: 80.5% for VH and 85.7% for VL.
  • Five distinct structural templates were used to build the antibody model.
  • All six loop templates have the same lengths as their corresponding target loops.
  • CDR-L1 has a mismatch in canonical structure classification despite matching loop length.
  • CDR-L2 has the lowest sequence identity to its selected loop template.
  • CDR-L3 is the longest loop in the LYRA model.
  • Several negatively charged residues are present in the CDRs, especially in the light chain.
  • Template similarity does not guarantee structural accuracy, particularly in flexible loops.

References